Bon Secours, Mercy Health announce merger

Two Catholic health systems, Maryland-based Bon Secours and Cincinnati’s Mercy Health have announced plans to merge into a 43-hospital system stretching across seven states in the eastern half of the U.S.

According to a joint press release, the merger would create the fifth-largest Catholic health system in the country, with a combined $8 billion in net operating revenue, $293 million in operating income and 2,100 employed physicians and advanced practice clinicians.

“As consumers grapple with the implications of Health Care Reform in a dynamic marketplace, Mercy Health and Bon Secours share a vision to improve the health of the communities we serve as the low-cost, high-value provider,” Mercy president and CEO John Starcher Jr. said in a statement. “Working together, our strong faith-based heritage fuels our mutual focus to provide efficient and effective healthcare for each patient who comes through our doors.”

Along with the 43 hospitals, the combined system would include more than 50 home health agencies, hospice agencies, skilled nursing and assisted living facilities. Those sites of care are located in Maryland, Virginia, South Carolina, Kentucky, Florida New York and Ohio.

The only in-state overlap between Mercy and Bon Secours can be found in Kentucky. Mercy operates three primary care clinics and one hospital, Marcum & Wallace Memorial, in rural areas southeast of Lexington. Its facilities are about a two-hour drive away from the Bon Secours-owned Our Lady of Bellefonte Hospital, a 214-bed acute care hospital in Ashland, Kentucky.

The two systems haven’t finalized a definitive merger agreement and the deal will require regulatory approval. Executives at both companies expect the transaction to be completed by the end of 2018.

“The mission, vision, values and geographic service areas of Bon Secours and Mercy Health are remarkably well-aligned and highly complementary,” said Bon Secours president and CEO Richard J. Statuto. “This merger strengthens our shared commitment to improve population health, eliminate health disparities, build strength to address social determinants of health, and invest heavily in innovating our approaches to healthcare.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.